1.Zhang F#, Zuo T#, Yeoh YK#, Cheng FW, Liu Q, Tang W, Cheung KC, Yang K, Cheung CP, Mo CC. longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease. Nature Communications. 2021, 12:1-11. (共同一作，影响因子: 17.694 , Q1)
2.Zhang F#, Wan Y#, Zuo T, Yeoh YK, Liu Q, Zhang L, Zhan H, Lu W, Xu W, Lui GC. Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology. 2022, 162(2):548-61. (共同一作，影响因子: 33.883, Q1，ESI高被引论文)
3.Zhang F, Aschenbrenner D, YooJY, Zuo T. The gut mycobiome in health, disease and clinical applications in association with the gut bacterial microbiome assembly. The LancetMicrobe. 2022, 3(12):969-983. (独立一作, IF 86.208，Q1).
4.Zhang F#, Lau Raphaela#, Liu Q, Ng SC.Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nature Reviews Gastroenterology & Hepatology. 2023,20:323–337. (共同一作，IF 73.082, Q1).
5.Zhang F, Ng SC. Reply: Gut microbiome metabolism drives the resolution of patients with COVID-19? Gastroenterology. 2022,163(1):337-338 (独立一作，影响因子: 33.883, Q1)
6.Zhang F#, Zuo T#, Wan YT，Xu ZL, Cheung CP, Li Amy, Zhu WY, Tang W, Chan KSP, Chan KLF, NG SC. Multi-omic Analysis Identified Duodenal and Colonic Mucosa Bacteria and Fecal Metabolites Associated with Weight Loss after Fecal Microbiota Transplantation in Obese Subjects.The innovation. 2022,13;3(5):100304. (共同一作，影响因子：32.1).
7.Zuo T#, Liu Q#, Zhang F#, Lui GC-Y, Tso EY, Yeoh YK, Chen Z, Boon SS, Chan FK, Chan PK. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut .2021,70(2), 276-284. (共同一作，影响因子: 31.739, Q1，ESI高被引论文)
8.Zuo T#, Liu Q#, Zhang F#, Yeoh YK, Wan Y, Zhan H, Lui GC, Chen Z, Li AY, Cheung CP. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity. Microbiome. 2021, 9:1-16. (共同一作, 影响因子: 16.837, Q1)
9.Zuo T#, Zhang F#, Lui GC#, Yeoh YK, Li AY, Zhan H, Wan Y, Chung AC, Cheung CP, Chen N. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020, 159:944-955. e8. (共同一作，影响因子: 33.883, Q1，ESI高被引论文)
10.Zhang F, Qiu L, Xu X, Liu Z, Zhan H, Tao X, Shah NP, Wei H. 2017. Beneficial effects of probiotic cholesterol-lowering strain of Enterococcus faecium WEFA23 from infants on diet-induced metabolic syndrome in rats. Journal of dairy science. 2017, 100:1618-1628. (独立一作，影响因子：4.034, Q1)
11.Zhang F, Jiang M, Wan C, Chen X, Chen X, Tao X, Shah NP, Wei H. Screening probiotic strains for safety: evaluation of virulence and antimicrobial susceptibility of enterococci from healthy Chinese infants. Journal of dairy science. 2016, 99:4282-4290. (独立一作，影响因子：4.034, Q1)